Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Site Randomized Controlled Trial of STARgraft (10401) Vascular Graft for Hemodialysis Access

NCT07557862 is registered in ClinicalTrials.gov with Healionics Corporation as lead sponsor.

NCT NCT07557862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07557862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Site Randomized Controlled Trial of STARgraft (10401) Vascular Graft for Hemodialysis Access
Lead sponsor
Healionics Corporation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
June 30, 2029
Enrollment
111 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd)